Key Clinical Insights from ECTRIMS 2012: Emerging Data on MS Treatment

Description

Faculty: Andrew N. Wilner, MD; Robert P. Lisak, MD; Omar A. Khan, MD This activity is intended for neurologists, primary care physicians, physical medicine and rehabilitation specialists, nurse practitioners, physician assistants, and nurses. The goal of this activity is to discuss new data on disease-modifying therapies for treatment of multiple sclerosis (MS) presented at the 28th Congress of the European Committee for Treatment and Research in MS (ECTRIMS). Upon completion of this activity, participants will be able to: 1.Assess new safety and efficacy data on MS disease-modifying therapies 2.Describe how emerging MS treatments may be integrated into clinical practice 3.Determine the potential of meeting data on MS treatments to enhance treatment responses Physicians - maximum of 1.25 AMA PRA Category 1 Credit(s)™

Visit the website